Document Detail

Trans-catheter closure of patent ductus arteriosus-What is the best device?
MedLine Citation:
PMID:  20815044     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Over the past three decades, transcatheter occlusion of patent ductus arteriosus (PDA) has evolved to be the procedure of choice. Gianturco and Flipper coils are the most commonly used coils in the United States for closure of small and moderate size PDAs. For larger PDAs, interventionalists in the United States commonly use the Amplatzer Duct Occluder (ADO) and those in Europe use the ADO or the Nit-Occlud Coils (NOC). A comparison between Gianturco coils, Flipper coils, ADO, and NOC has never been made.
OBJECTIVE: To compare the success and complication rate associated with the four different devices used for transcatheter closure of PDA. Success was defined as complete closure of PDA with absence of a residual shunt (R.S.) at six months follow-up.
METHODS: Two institutions collaborated in combining their data to evaluate the results of transcatheter closure of PDA.
RESULTS: Totally, 546 patients underwent successful PDA occlusion at both institutions. Gianturco and Flipper coils were used in 120 (22%) and 119 (22%) patients respectively. A total of 152 (28%) patients received ADO and 155 (28%) patients received NOC. Immediate R.S. were noted in 226 (41.4%) patients in the entire study group with the NOC group having the highest percentage of R.S. (80/155, 51.6%, P = 0.004). Of the 484 patients with follow-up echocardiograms at 6 months, 35 (7.2%) patients had persistent R.S. The NOC (3/143, 2.1%) and ADO (5/150, 3.3%) groups had the least R.S. at six months follow-up.
CONCLUSION: Per our definition of success, the Nit-Occlud coils and the Amplatzer duct-occluder devices had significantly higher success rate for PDA occlusion versus the coils. © 2010 Wiley-Liss, Inc.
Abdolrahim Ghasemi; Swati Pandya; Surendranath Veeram Reddy; Daniel R Turner; Wei Du; Mohamad Ali Navabi; Mohammad Reza Mirzaaghayan; Abdolrazagh Kiani; Katherine Sloan; Thomas J Forbes
Related Documents :
8176584 - Treatment of bleeding esophagogastric varices due to extrahepatic portal hypertension: ...
11150444 - Portal venous decompression with h-type mesocaval shunt using autologous vein graft: a ...
23350994 - Effects of omalizumab in non-atopic asthma: results from a spanish multicenter registry.
19299324 - Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
21777324 - Healthcare utilization and expenditures in patients with atrial fibrillation treated wi...
16394604 - Newly diagnosed acute aortic dissection: characteristics, treatment modifications, and ...
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  76     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-26     Completed Date:  2011-02-09     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  687-95     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiac Catheterization / adverse effects,  instrumentation*
Chi-Square Distribution
Child, Preschool
Ductus Arteriosus, Patent / radiography,  therapy*,  ultrasonography
Infant, Newborn
Patient Selection
Prosthesis Design
Retrospective Studies
Risk Assessment
Risk Factors
Septal Occluder Device*
Time Factors
Treatment Outcome
Comment In:
Catheter Cardiovasc Interv. 2010 Nov 1;76(5):703-4   [PMID:  20976751 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of ang...
Next Document:  Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in dia...